Canada markets close in 1 hour 17 minutes

BeiGene, Ltd. (BGNE)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
252.71-3.29 (-1.29%)
As of 02:43PM EST. Market open.
Full screen
Loading interactive chart...
  • Business Wire

    BeiGene to Present at Upcoming Investor Conferences

    CAMBRIDGE, Mass. & BASEL, Switzerland & BEIJING, February 01, 2023--BeiGene announced that the Company will participate in two upcoming investor conferences.

  • Zacks

    Jazz (JAZZ) Gastric Cancer Study Shows Improved Overall Survival

    Jazz (JAZZ) reports data from a mid-stage study on its investigational bispecific antibody targeting HER2-expressing mGEA. The treatment achieved an overall survival rate of 84% in 18 months.

  • Business Wire

    BRUKINSA® Approved in the U.S. for Chronic Lymphocytic Leukemia

    BASEL, Switzerland & BEIJING & CAMBRIDGE, Mass., January 19, 2023--BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company, today announced that the U.S. Food and Drug Administration (FDA) has approved its Bruton’s tyrosine kinase inhibitor (BTKi) BRUKINSA (zanubrutinib) for the treatment of adult patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL).